Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian J. Sperling is active.

Publication


Featured researches published by Brian J. Sperling.


Cornea | 2015

Outcomes After Descemet Stripping Automated Endothelial Keratoplasty in Patients With Glaucoma Drainage Devices.

Nina Ni; Brian J. Sperling; Yang Dai; Sadeer B. Hannush

Purpose: To evaluate outcomes after Descemet stripping automated endothelial keratoplasty in eyes with glaucoma drainage devices. Methods: This is a retrospective review of 24 cases performed by a single surgeon (S.B.H.) on 20 eyes. Data were gathered on demographics, ocular history, surgical details, and postoperative outcomes. Outcome measures included primary graft failure, secondary graft failure, endothelial cell density (ECD), central corneal thickness (CCT), intraocular pressure, and visual acuity. Results: With a mean follow-up of 30.3 ± 19.6 months, there was no occurrence of primary graft failure, and the rate of secondary graft failure was 29%. Survival rates at 1, 2, and 3 years, respectively, were 87% [95% confidence interval (CI): 65%–96%], 80% (95% CI: 55%–92%), and 70% (95% CI: 39%–88%). Compared with ECD of the donor lenticule, endothelial cell loss was 49 ± 16% (n = 21) at postoperative month 3, 59 ± 16% (n = 20) at month 6, 61 ± 20% (n = 16) at month 12, and stabilized at 75 ± 17% (n = 9) by month 18. Compared with CCT during the visit before surgery, CCT decreased to 83 ± 18% (n = 18) at postoperative month 3 and gradually increased to 95 ± 11% (n = 6) at month 24. There were 4 (17%) cases of intraocular pressure elevation above 25 mm Hg. Improved visual acuity occurred in 71% of patients. Conclusions: Descemet stripping automated endothelial keratoplasty in eyes with corneal edema secondary to endothelial dysfunction in the presence of a previous glaucoma drainage device is a successful procedure. However, intermediate term endothelial cell loss is significant, as is the graft failure rate.


Cornea | 2014

Descemet stripping endothelial keratoplasty for the treatment of combined fuchs corneal endothelial dystrophy and keratoconus.

Samir Vira; Usiwoma Abugo; Carolyn Shih; Ira J. Udell; Brian J. Sperling; Sadeer B. Hannush; Surendra Basti; Charles S. Bouchard

Purpose: To report the first case series of patients with Fuchs corneal endothelial dystrophy (FCD) and keratoconus (KCN) who underwent Descemet stripping endothelial keratoplasty (DSEK). Methods: This is a retrospective case series of 6 eyes of 4 patients with combined FCD and KCN who underwent DSEK at 3 different centers. Clinical information collected included corneal topography measurements, central corneal thickness, and endothelial cell count. Visual outcomes and change in keratometric measurements were evaluated. Results: The follow-up for patients ranged from 10 to 72 months. The best-corrected visual acuity was 20/40 or better in all 6 eyes. The mean keratometric measurements decreased in all cases (range of 0.5–5.8 diopters); however, topography still demonstrated an inferior steepening in each case. Conclusions: Patients with FCD and KCN have been previously reported as being managed with penetrating keratoplasty. We present 6 eyes of 4 patients who were managed with DSEK for the FCD. Topographically, the characteristic inferior steepening of KCN did not change; however, all patients with DSEK had flatter postoperative keratometric measurements with improved visual acuity. If a DSEK is performed for FCD before apical corneal scarring from KCN, a good visual outcome may be achieved.


publisher | None

title

author


Investigative Ophthalmology & Visual Science | 2015

Three-Year Follow Up of DSAEK Failure Rates and Endothelial Cell Loss in Eyes with Glaucoma Drainage Devices

Brenton D. Finklea; Nina Ni; Brian J. Sperling; Sadeer B. Hannush


Investigative Ophthalmology & Visual Science | 2014

Endothelial Cell Loss After Descemet’s Stripping Automated Endothelial Keratoplasty in Glaucoma Patients With Glaucoma Drainage Devices

Nina Ni; Brian J. Sperling; Sadeer B. Hannush


Investigative Ophthalmology & Visual Science | 2012

Two-year data on Endothelial Cell Loss After DSAEK with Forceps Insertion and Neusidl Corneal Inserter

Lorena Riveroll-Hannush; Sadeer B. Hannush; Brian J. Sperling


Investigative Ophthalmology & Visual Science | 2012

Surgical Management and Outcomes of Patients with Concurrent Fuchs’ Corneal Endothelial Dystrophy and Keratoconus - A Multi-Center Case Series

Charles S. Bouchard; Samir Vira; Usiwoma Abugo; Brian J. Sperling; Surendra Basti; Sadeer B. Hannush


Investigative Ophthalmology & Visual Science | 2011

Endothelial Cell Loss During DSAEK With Traditional Forceps Insertion And Neusidl Corneal Inserter

Sadeer B. Hannush; Lorena Riveroll-Hannush; Brian J. Sperling


Investigative Ophthalmology & Visual Science | 2010

Timeline of Endothelial Cell Loss After the New Corneal Triple Procedure

Sadeer B. Hannush; Brian J. Sperling; Lorena Riveroll-Hannush; N. Lee


Investigative Ophthalmology & Visual Science | 2009

Visual Rehabilitation With the New Corneal Triple Procedure

Sadeer B. Hannush; N. Lee; Brian J. Sperling

Collaboration


Dive into the Brian J. Sperling's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Samir Vira

Loyola University Chicago

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Usiwoma Abugo

Loyola University Chicago

View shared research outputs
Top Co-Authors

Avatar

Brenton D. Finklea

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Carolyn Shih

North Shore-LIJ Health System

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge